Paper41449347
Comparative analysis of drug susceptibility among different Mycobacterium abscessus morphotypes.
Cheng K and 5 others. BMC Microbiol, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Comparative analysis of drug susceptibility among different Mycobacterium abscessus morphotypes. Papers, record 41449347. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41449347
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Comparative analysis of drug susceptibility among different Mycobacterium abscessus morphotypes.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Mycobacterium abscessus | Major topic |
| Anti-Bacterial Agents | Major topic |
| Drug Resistance, Multiple, Bacterial | Major topic |
| Microbial Sensitivity Tests | |
| Humans | |
| Clofazimine | |
| Mycobacterium Infections, Nontuberculous | |
| Phenotype | |
| Genotype | |
| Fluoroquinolones |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Z221100007422056 | Beijing Municipal Science & Technology Commission | PubMed | ||
| 20230484295 | Beijing Nova Program | PubMed |
Source PubMed
References26
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 40199904 | A glycosylated lipooctapeptide promotes uptake and growth of Mycobacterium abscessus in the host. | Nat Commun | 2025 | https://conductscience.org/library/papers/40199904 | PubMed |
| 2 | 20833823 | Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus. | Am J Respir Crit Care Med | 2011 | https://conductscience.org/library/papers/20833823 | PubMed |
| 3 | 15295701 | Production of exopolysaccharide by Burkholderia cenocepacia results in altered cell-surface interactions and altered bacterial clearance in mice. | J Infect Dis | 2004 | https://conductscience.org/library/papers/15295701 | PubMed |
| 4 | 17277290 | An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. | Am J Respir Crit Care Med | 2007 | https://conductscience.org/library/papers/17277290 | PubMed |
| 5 | 32617011 | Antimicrobial Susceptibility of Mycobacterium abscessus Complex Clinical Isolates from a Chinese Tertiary Hospital. | Infect Drug Resist | 2020 | https://conductscience.org/library/papers/32617011 | PubMed |
| 6 | 33731862 | Association between 16S rRNA gene mutations and susceptibility to amikacin in Mycobacterium avium Complex and Mycobacterium abscessus clinical isolates. | Sci Rep | 2021 | https://conductscience.org/library/papers/33731862 | PubMed |
| 7 | 31512604 | A multilocus sequence typing scheme for Mycobacterium abscessus complex (MAB-multilocus sequence typing) using whole-genome sequencing data. | Int J Mycobacteriol | 2019 | https://conductscience.org/library/papers/31512604 | PubMed |
| 8 | 23030647 | Phagocytosis and cytokine response to rough and smooth colony variants of Mycobacterium abscessus by human peripheral blood mononuclear cells. | APMIS | 2013 | https://conductscience.org/library/papers/23030647 | PubMed |
| 9 | 11158161 | Fatal pulmonary infection due to multidrug-resistant Mycobacterium abscessus in a patient with cystic fibrosis. | J Clin Microbiol | 2001 | https://conductscience.org/library/papers/11158161 | PubMed |
| 10 | 31540480 | The Contribution of Efflux Pumps in Mycobacterium abscessus Complex Resistance to Clarithromycin. | Antibiotics (Basel) | 2019 | https://conductscience.org/library/papers/31540480 | PubMed |
| 11 | 34108590 | Nationwide surveillance of antimicrobial susceptibility of 509 rapidly growing mycobacteria strains isolated from clinical specimens in Japan. | Sci Rep | 2021 | https://conductscience.org/library/papers/34108590 | PubMed |
| 12 | 26288841 | Azithromycin Synergizes with Cationic Antimicrobial Peptides to Exert Bactericidal and Therapeutic Activity Against Highly Multidrug-Resistant Gram-Negative Bacterial Pathogens. | EBioMedicine | 2015 | https://conductscience.org/library/papers/26288841 | PubMed |
| 13 | 27385830 | Deletion of a dehydratase important for intracellular growth and cording renders rough Mycobacterium abscessus avirulent. | Proc Natl Acad Sci U S A | 2016 | https://conductscience.org/library/papers/27385830 | PubMed |
| 14 | 30687747 | In Vitro Susceptibility of Mycobacterium abscessus and Mycobacterium fortuitum Isolates to 30 Antibiotics. | Biomed Res Int | 2018 | https://conductscience.org/library/papers/30687747 | PubMed |
| 15 | 37862100 | Population heterogeneity in Mycobacterium smegmatis and Mycobacterium abscessus. | Microbiology (Reading) | 2023 | https://conductscience.org/library/papers/37862100 | PubMed |
| 16 | 24197890 | Characterization of rough and smooth morphotypes of Mycobacterium abscessus isolates from clinical specimens. | J Clin Microbiol | 2014 | https://conductscience.org/library/papers/24197890 | PubMed |
| 17 | 40105336 | Subspecies distribution and drug-resistance characteristics of Mycobacterium abscessus complex clinical isolates in South China. | Microbiol Spectr | 2025 | https://conductscience.org/library/papers/40105336 | PubMed |
| 18 | 22290346 | Mycobacterium abscessus: a new antibiotic nightmare. | J Antimicrob Chemother | 2012 | https://conductscience.org/library/papers/22290346 | PubMed |
| 19 | 16735722 | Spontaneous reversion of Mycobacterium abscessus from a smooth to a rough morphotype is associated with reduced expression of glycopeptidolipid and reacquisition of an invasive phenotype. | Microbiology (Reading) | 2006 | https://conductscience.org/library/papers/16735722 | PubMed |
| 20 | 32636299 | Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline. | Eur Respir J | 2020 | https://conductscience.org/library/papers/32636299 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41449347
GET https://conductscience.org/api/papers/v1/41449347/references?page=2